This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Acupuncture and Relaxation Response for GI Symptoms and HIV Medication Adherence

This study has been completed.
Sponsor:
Collaborator:
National Center for Complementary and Integrative Health (NCCIH)
Information provided by (Responsible Party):
Bei-Hung Chang, Boston University
ClinicalTrials.gov Identifier:
NCT00545623
First received: October 15, 2007
Last updated: August 31, 2014
Last verified: August 2014
Results First Received: July 25, 2014  
Study Type: Interventional
Study Design: Allocation: Randomized;   Intervention Model: Factorial Assignment;   Masking: Double Blind (Participant, Investigator, Outcomes Assessor);   Primary Purpose: Treatment
Condition: HIV Infections
Interventions: Procedure: Acupuncture
Behavioral: Relaxation Response
Other: sham acupuncture

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
ACUP+RR

acupuncture + relaxation response CD

Acupuncture: acupuncture twice/week for the first 4 weeks and once/week for another 4 weeks

Relaxation Response: listening to CDs with verbal instructions of techniques to elicit relaxation response

SHAM+RR

sham acupuncture + relaxation response CD

Relaxation Response: listening to CDs with verbal instructions of techniques to elicit relaxation response

ACUP+EDU

acupuncture+education CD

Acupuncture: acupuncture twice/week for the first 4 weeks and once/week for another 4 weeks

SHAM+EDU

sham acupuncture+education CD

sham acupuncture: sham acupuncture twice/week for the first 4 weeks and once/week for another 4 weeks


Participant Flow:   Overall Study
    ACUP+RR   SHAM+RR   ACUP+EDU   SHAM+EDU
STARTED   32   31   33   34 
COMPLETED   25   21   20   23 
NOT COMPLETED   7   10   13   11 



  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
A total of 15 patients did not start the intervention after enrollment, 1, 4, 6, and 4 patients in ACUP+RR, SHAM+RR, ACUP+EDU, and SHAM+EDU arms respectively. As such there are a total of 115 patients with baseline data.

Reporting Groups
  Description
ACUP+RR

acupuncture + relaxation response CD

Acupuncture: acupuncture twice/week for the first 4 weeks and once/week for another 4 weeks

Relaxation Response: listening to CDs with verbal instructions of techniques to elicit relaxation response

SHAM+RR

sham acupuncture + relaxation response CD

Relaxation Response: listening to CDs with verbal instructions of techniques to elicit relaxation response

ACUP+EDU

acupuncture+education CD

Acupuncture: acupuncture twice/week for the first 4 weeks and once/week for another 4 weeks

SHAM+EDU

sham acupuncture+education CD

sham acupuncture: sham acupuncture twice/week for the first 4 weeks and once/week for another 4 weeks

Total Total of all reporting groups

Baseline Measures
   ACUP+RR   SHAM+RR   ACUP+EDU   SHAM+EDU   Total 
Overall Participants Analyzed 
[Units: Participants]
 31   27   27   30   115 
Age 
[Units: Years]
Mean (Standard Deviation)
 47.2  (8.8)   45.0  (7.1)   47.1  (9.9)   47.0  (8.2)   46.6  (8.5) 
Gender 
[Units: Participants]
         
Female   9   9   7   9   34 
Male   22   18   20   21   81 
Region of Enrollment 
[Units: Participants]
         
United States   31   27   27   30   115 


  Outcome Measures

1.  Primary:   Changes in GI Symptom Per Intervention Session   [ Time Frame: 8 weeks ]


  Serious Adverse Events


  Other Adverse Events


  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.


  More Information
  Hide More Information

Certain Agreements:  
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.


Results Point of Contact:  
Name/Title: Bei-Hung Chang
Organization: Boston University
phone: 508-856-8959
e-mail: bhchang@bu.edu


Publications of Results:

Responsible Party: Bei-Hung Chang, Boston University
ClinicalTrials.gov Identifier: NCT00545623     History of Changes
Other Study ID Numbers: R21AT003377-01 ( U.S. NIH Grant/Contract )
Study First Received: October 15, 2007
Results First Received: July 25, 2014
Last Updated: August 31, 2014